High-flow nasal cannula therapy reduced intubation rates in critically ill Pneumocystis pneumonia patients, though survival benefits were not observed, in a multicenter retrospective analysis.

T-cell therapy and bispecific antibodies are transforming multiple myeloma care, with earlier use, expanded community access, and outpatient delivery models offering opportunities to improve value, ...

Barriers to CAR T-cell therapy exist for patients with multiple myeloma, even in urban areas, said Mary Steinbach, DNP, APRN, ...